Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3573 | 939 | 40.3 | 89% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
18007 | 509 | ALCAM//CD166//CD6 |
24882 | 249 | GICERIN//CD146//NEURITE OUTGROWTH FACTOR |
27795 | 181 | AGR2//C44A//LYPD3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AGR2 | Author keyword | 110 | 95% | 4% | 37 |
2 | ALCAM | Author keyword | 64 | 72% | 5% | 50 |
3 | GICERIN | Author keyword | 41 | 100% | 2% | 15 |
4 | CD146 | Author keyword | 28 | 47% | 5% | 44 |
5 | CD166 | Author keyword | 23 | 56% | 3% | 28 |
6 | CD6 | Author keyword | 17 | 59% | 2% | 19 |
7 | NEURITE OUTGROWTH FACTOR | Author keyword | 14 | 100% | 1% | 7 |
8 | C44A | Author keyword | 11 | 78% | 1% | 7 |
9 | CD72 | Author keyword | 9 | 43% | 2% | 17 |
10 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | Author keyword | 9 | 64% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AGR2 | 110 | 95% | 4% | 37 | Search AGR2 | Search AGR2 |
2 | ALCAM | 64 | 72% | 5% | 50 | Search ALCAM | Search ALCAM |
3 | GICERIN | 41 | 100% | 2% | 15 | Search GICERIN | Search GICERIN |
4 | CD146 | 28 | 47% | 5% | 44 | Search CD146 | Search CD146 |
5 | CD166 | 23 | 56% | 3% | 28 | Search CD166 | Search CD166 |
6 | CD6 | 17 | 59% | 2% | 19 | Search CD6 | Search CD6 |
7 | NEURITE OUTGROWTH FACTOR | 14 | 100% | 1% | 7 | Search NEURITE+OUTGROWTH+FACTOR | Search NEURITE+OUTGROWTH+FACTOR |
8 | C44A | 11 | 78% | 1% | 7 | Search C44A | Search C44A |
9 | CD72 | 9 | 43% | 2% | 17 | Search CD72 | Search CD72 |
10 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | 9 | 64% | 1% | 9 | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALCAM | 103 | 91% | 4% | 42 |
2 | AGR2 | 99 | 93% | 4% | 38 |
3 | NEURITE OUTGROWTH FACTOR | 81 | 96% | 3% | 25 |
4 | ALCAM CD166 | 76 | 81% | 5% | 46 |
5 | ANTERIOR GRADIENT 2 | 59 | 90% | 3% | 26 |
6 | MUC18 | 58 | 83% | 4% | 33 |
7 | CD6 LIGAND | 44 | 100% | 2% | 16 |
8 | MONOCLONAL ANTI LYB 2 ANTIBODY | 38 | 93% | 1% | 14 |
9 | ANTI CD6 MONOCLONAL ANTIBODY | 38 | 86% | 2% | 19 |
10 | GENE XAG 2 | 36 | 83% | 2% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CD146, a multi-functional molecule beyond adhesion | 2013 | 32 | 150 | 81% |
Activated leukocyte cell adhesion molecule: a new paradox in cancer | 2008 | 64 | 47 | 83% |
Anterior gradient 2: A novel player in tumor cell biology | 2011 | 39 | 42 | 64% |
Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development | 2013 | 16 | 73 | 42% |
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker | 2013 | 13 | 69 | 49% |
Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146 | 2009 | 53 | 98 | 58% |
CD6-ligand interactions: a paradigm for SRCR domain function? | 1997 | 102 | 39 | 67% |
The scavenger receptor cysteine-rich (SRCR) domain: An ancient and highly conserved protein module of the innate immune system | 2004 | 123 | 245 | 30% |
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator | 2004 | 52 | 37 | 51% |
The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease | 2011 | 15 | 54 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAS UNIV TOKYO JOINT STRUCT VIROL IMMUNOL | 5 | 50% | 0.7% | 7 |
2 | MOL BIOMED PATHOGENESIS | 4 | 36% | 0.9% | 8 |
3 | COMPUTAT LINGUIST | 4 | 13% | 2.7% | 25 |
4 | STANFORD DIGEST DIS | 3 | 60% | 0.3% | 3 |
5 | MD ANDERSON CANCER CELL BIOL | 2 | 67% | 0.2% | 2 |
6 | GRP CELL ACTIVAT GENE EXP S | 2 | 40% | 0.4% | 4 |
7 | PROT PEPTIDE PHARMACEUT | 2 | 14% | 1.4% | 13 |
8 | CHINESE SCI UNIV TOKYO JOINT STRUCT VIRO | 2 | 36% | 0.4% | 4 |
9 | MED PHARMACOL 1 | 2 | 43% | 0.3% | 3 |
10 | CANC UK SIGNAL TRANSDUCT S P53 | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018178 | TENASCIN C//TENASCIN//POLYSIALIC ACID |
2 | 0.0000015310 | CD24//NDRG2//NDRG1 |
3 | 0.0000011785 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
4 | 0.0000011724 | E CADHERIN//CADHERIN//CATENINS |
5 | 0.0000011038 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
6 | 0.0000010777 | BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6 |
7 | 0.0000010311 | SEMAPHORIN//EPHRIN//PLEXIN |
8 | 0.0000009228 | EZRIN//MOESIN//RADIXIN |
9 | 0.0000008867 | SEROFENDIC ACID//COSALANE//AURINTRICARBOXYLIC ACID |
10 | 0.0000008598 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |